Associated Papers
Molecular mechanisms of SLC30A10-mediated manganese transport.
Shen X et al.
Nature Communications, 2025
41022720 (PubMed )
Supplement: 41467_2025_63616_MOESM1_ESM.pdf
Consensus of Expert Opinion for the Diagnosis and Management of Hypermanganesaemia With Dystonia 1 and 2.
Fang S et al.
Journal of Inherited Metabolic Disease, 2025
Case Report: Childhood Erythrocytosis due to Hypermanganesemia Caused by Homozygous SLC30A10 Mutation.
Coppola T et al.
Frontiers in Hematology, 2024
Familial Hypermanganesemia in Iran.
Tabatabaee SN et al.
Movement Disorders Clinical Practice, 2023
Clinical Profile and Treatment Outcomes of Hypermanganesemia with Dystonia 1 and 2 among 27 Indian Children.
Garg D et al.
Movement Disorders Clinical Practice, 2022
A case of dystonia with polycythemia and hypermanganesemia caused by SLC30A10 mutation: a treatable inborn error of manganese metabolism.
Tavasoli A et al.
Bmc Pediatrics, 2019
Genetic Disorders of Manganese Metabolism.
Anagianni S et al.
Current Neurology and Neuroscience Reports, 2019
Hypermanganesemia with Dystonia, Polycythemia and Cirrhosis (HMDPC) due to mutation in the SLC30A10 gene.
Mukhtiar K et al.
Brain & Development, 2016
Select a paper to view details